Page 23 - Delaware Medical Journal - July/August 2020

CASE STUDY
CONTRIBUTORS
■ MARK J. BOYTIM, MD trained as an orthopaedic surgeon. He is Co-Director of Beebe Healthcare's Post-Acute Care Network and a member of the Population Health Team at Beebe Healthcare.
■ WILLIAM CHASANOV, DO, MBA is an internal medicine, infectious diseases physician. He is the Clinical Transformation Officer and Medical Director for Employee Health at Beebe Healthcare in Lewes.
■ NGOZI AZUOGU MSN, RN is the Data Activation Specialist for Beebe Healthcare’s Population Health Department. Azuogu also is an adjunct faculty member in the School of Nursing at Delaware State University.
■ REBECCA MARCINAK, PHARMD is the Infectious Diseases/Antimicrobial Stewardship Pharmacist at Beebe Healthcare. ■ DIANE TAYLOR is Director of Financial Planning & Decision Support for Beebe Healthcare.
■ HALEY WINWARD is the Data Analyst for Beebe Healthcare’s Population Health Department.
REFERENCES
1. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929- 936.
2. Qun Li M, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207.
3. Public Health Announces First Presumptive Positive Case of Coronavirus in Delaware Resident. State of Delaware News. https://news. delaware.gov/2020/03/11/public-health-announces-first-presumptive-positive-case-of-coronavirus-in-delaware-resident/. Published March 12, 2020. Accessed July 1, 2020.
4. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
5. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Preprint. medRxiv. 2020;2020.04.15.20067157. Published 2020 Apr 20.
6. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382(21):2012-2022.
7. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.
8. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]. JAMA Intern Med. 2020;e200994.
9. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol. 2020;92(7):814-818.
10. Capra R, De Rossi N, Mattioli F, et al. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia. Eur J Intern Med. 2020;76:31-35.
11. Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970-10975.
12. U.S. Census Bureau QuickFacts: Sussex County, Delaware; Delaware. Census Bureau QuickFacts. https://www.census.gov/quickfacts/ fact/table/sussexcountydelaware,DE/PST045219. Published 2019. Accessed July 1, 2020.
13. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non- randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;105949.
14. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020;34:101663.
15. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 [published online ahead of print, 2020 Apr 27]. Clin Infect Dis. 2020;ciaa478.
16. Fadel R, Morrison AR, Vahia A, et al. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 [published online ahead of print, 2020 May 19]. Clin Infect Dis. 2020;ciaa601.
17. Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683-684.
18. Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582- 1589.
19. Zhang B, Liu S, Tan T, et al. Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Chest. 2020;31:S0012-3692(20)30571-7.
Del Med J | July/August 2020 | Vol. 92 | No. 4 167